3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
31
Recruiting
7
Unknown
6
Withdrawn
2
Terminated
2
Active not recruiting
2
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Neuromuscular Diseases
1
Myotonic Dystrophy
1
Myositis, Inclusion Body
1
Muscular Dystrophy, Facioscapulohumeral
1
Muscular Dystrophies, Limb-Girdle
1
Muscular Atrophy, Spinal
1
Lambert-Eaton Myasthenic Syndrome
1
Hereditary Sensory and Motor Neuropathy
1
Guillain-Barre Syndrome
1
Glycogen Storage Disease Type II
1
Friedreich Ataxia
1
Interventions
Cisplatin
9
Standard of Care
6
Educational Status
6
Nivolumab
5
Interviews as Topic
5
Carboplatin
5
Radiotherapy
4
Paclitaxel
4
Oxaliplatin
4
Dexamethasone
4
pembrolizumab
3
camrelizumab
3
Practice Guidelines as Topic
3
Patient Navigation
3
Methods
3
Magnetic Resonance Spectroscopy
3
Magnetic Resonance Imaging
3
Lenalidomide
3
Fluorouracil
3
Fluorodeoxyglucose F18
3
Exercise
3
Early Intervention, Educational
3
Drug Therapy
3
Cytarabine
3
130-nm albumin-bound paclitaxel
3
venetoclax
2
toripalimab
2
tislelizumab
2
sacituzumab govitecan
2
lenvatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Interventional
×
Physical Therapy Modalities
×
Clear all
NCT07072676
2025-07-18
Risk of fall
LMU Klinikum
Phase NA
Enrolling by invitation
30 enrolled